Life Money USA
Business Sale & Exit Planning

QSBS Across 5 C-Corps: Stacking 5 $10M Exclusions for Founders

A serial founder asks a deceptively simple question: if I build and sell five C-corporations over the next 20 years, do I get five $10 million QSBS exclusions, or do I get one shared $10 million cap across all of them? The statutory answer under IRC section 1202(b)(1) is unambiguous — the exclusion is computed per issuer. Five qualifying corporations generate five independent $10 million exclusions, for a combined $50 million of federal tax-free capital gain. There is no aggregation rule. There is no lifetime cap across issuers. The IRS has never argued otherwise. But every one of those five corporations must independently satisfy every requirement of section 1202 — the $50 million gross-asset test, the active-business test, the original-issuance requirement, and the 5-year holding period — and a single disqualification in one company does not extend to the others but also cannot be salvaged. For founders contemplating a serial-entrepreneurship arc, understanding how stacking actually works in practice is the difference between a $50 million federal tax bill of $0 and one north of $10 million.

Jennifer Park, CPA, EA, MST
Tax Planning + Business Sale Specialist
Updated May 22, 2026
16 min
2026 verified
Share

The question comes up in every founder conversation that runs long enough: if QSBS gives me a $10 million federal exclusion on one company, can I get $50 million across five? The statute is clear. IRC section 1202(b)(1) defines the exclusion as the greater of $10 million or 10 times the taxpayer's adjusted basis in qualified small business stock, computed "with respect to each corporation." There is no aggregation rule. There is no lifetime cap. Five qualifying C-corporations, each held for 5+ years and each independently meeting every section 1202 requirement, generate five independent $10 million exclusions.

Short answer: yes, five stacking exclusions are statutorily permitted. The hard part is not the law — it is the execution. Every company must satisfy the gross-asset test at issuance, conduct an active qualified trade or business throughout the holding period, and survive any redemption or restructuring that could disqualify the stock. A serial founder who builds five companies over 20 years and gets the structuring right at each one can compound $50 million of federal tax-free capital gain. A founder who gets one wrong loses that company's exclusion entirely — but the other four are unaffected.

The per-issuer rule: statutory text and IRS treatment

IRC section 1202(b)(1) defines the eligible gain cap as "the greater of (A) $10,000,000 reduced by the aggregate amount of eligible gain taken into account by the taxpayer in prior taxable years with respect to dispositions of stock issued by such corporation, or (B) 10 times the aggregate adjusted basis of qualified small business stock issued by such corporation and disposed of by the taxpayer during the taxable year."

The phrase "such corporation" — appearing in both prongs — is the operative language. The exclusion is computed corporation-by-corporation. There is no provision in section 1202, its regulations, or its legislative history that aggregates exclusions across issuers. The IRS has issued multiple private letter rulings confirming the per-issuer interpretation (PLR 200532012, PLR 201503010, among others), and no Treasury regulation or revenue ruling has ever suggested an aggregate cap.

What this means in practice: a founder who exits Company A in 2026 and excludes $10 million has not consumed any portion of the available exclusion on Company B, Company C, Company D, or Company E. Each of those companies, when sold, generates its own independent $10 million cap (or 10x basis, if greater). The five exclusions are statutorily orthogonal.

The five gates each company must clear

For each company in a 5-company stack, all five section 1202 requirements must be satisfied independently. Failure on any single requirement disqualifies that company's exclusion — but not the others.

Gate 1: Domestic C-corporation at original issuance

Under IRC section 1202(c)(1), the issuer must be a domestic C-corporation at the time the taxpayer acquires the stock at original issuance. S-corporations do not qualify. LLCs taxed as partnerships do not qualify. LLCs that have elected C-corp tax treatment under check-the-box rules may qualify, but the safer path is incorporating as a Delaware C-corporation from day one. For a 5-company stack, this means each entity is incorporated as a C-corp before any stock issuance — converting from LLC to C-corp later starts the 5-year holding-period clock at conversion, not at the company's founding.

Gate 2: $50 million gross-asset test at issuance

IRC section 1202(d)(1) requires that the corporation's aggregate gross assets — cash plus the adjusted basis of all other property held — not exceed $50 million at any time on or before the date of stock issuance, including immediately after the issuance. The test uses tax basis (not fair market value), so a company whose tangible assets are highly depreciated may still qualify even if its enterprise value is well above $50 million.

Cash received in connection with the stock issuance counts toward the $50 million ceiling on the date of issuance. A founder who incorporates Company B in 2025, takes a $48 million Series A, and grants additional founder shares post-financing has crossed the threshold — the new founder shares are not QSBS. Stock issued before the threshold was crossed remains QSBS. The test is issuance-date-specific.

Gate 3: Active qualified trade or business (80% test)

Under IRC section 1202(e)(1), at least 80% of the corporation's assets (by value) must be used in the active conduct of one or more qualified trades or businesses during substantially all of the taxpayer's holding period. IRC section 1202(e)(3) excludes specific industries: health, law, engineering, architecture, accounting, actuarial science, performing arts, consulting, athletics, financial services, brokerage, banking, insurance, farming, mining, hotels, motels, restaurants, and any business where the principal asset is the reputation or skill of one or more employees.

For a 5-company stack to clear this gate consistently, the founder typically operates in technology, SaaS, e-commerce, manufacturing, biotechnology, hardware, or product businesses — the industries that have driven the bulk of QSBS exit value over the past 15 years. A founder running five consulting practices cannot stack. A founder running five SaaS companies can.

Gate 4: Original issuance to the taxpayer

IRC section 1202(c)(1)(B) requires that the taxpayer acquire the stock at its original issuance — directly from the company — in exchange for money, property (other than stock), or services. Stock purchased on the secondary market does not qualify, even if the company would otherwise meet all other requirements. For a 5-company stack, this means each tranche of founder stock is issued directly by the company to the founder, in exchange for cash investment or services (with an 83(b) election filed within 30 days to establish basis and start the holding-period clock).

Gate 5: 5-year holding period per issuer

IRC section 1202(b)(2) requires that the taxpayer hold the QSBS for more than 5 years before sale. The clock runs separately for each company and each tranche of stock. Holding Company A for 7 years does not credit any time to Company B. For a 5-company stack with sequential founding dates, the founder's exits must be timed so each company is held at least 5 years from its respective stock-issuance date.

Worked example: a Bay Area serial founder, 5 companies, 20 years

Consider a Bay Area founder who builds and sells five C-corporations between 2020 and 2040. Each company is incorporated in Delaware as a C-corp on day one. The founder makes timely 83(b) elections on all founder stock. Each company is a B2B SaaS or developer-tools business — clearly within the active-business definition of section 1202(e)(1).

The five exits

  • Company 1 — DataPath Inc. Incorporated January 2020. Founder invested $200,000 cash for 6 million shares; 83(b) election filed within 30 days establishing $200,000 basis. Raised a $4M seed and $14M Series A; gross assets peaked at $19 million (under the $50M ceiling). Sold to a strategic acquirer in March 2026 for $24 million. Founder's 55% stake yields $13.2 million.
  • Company 2 — InferLab Inc. Incorporated October 2022 while DataPath was still operating. Founder invested $400,000 for 5 million shares with 83(b) election. Bootstrapped; gross assets never exceeded $8 million. Sold in November 2028 for $18 million. Founder's 70% stake yields $12.6 million.
  • Company 3 — QueueShift Inc. Incorporated June 2026. Founder invested $1 million for 4 million shares with 83(b) election. Raised a $9M Series A; gross assets peaked at $11 million. Sold in August 2032 for $30 million. Founder's 45% stake yields $13.5 million.
  • Company 4 — RegEdge Inc. Incorporated April 2029. Founder invested $1.5 million for 5 million shares with 83(b) election. Raised a $20M Series A and $35M Series B; gross assets peaked at $48 million (just under the ceiling). Sold in July 2035 for $48 million. Founder's 30% stake yields $14.4 million.
  • Company 5 — Vectorline Inc. Incorporated February 2033. Founder invested $2 million for 6 million shares with 83(b) election. Sold in March 2039 for $22 million. Founder's 60% stake yields $13.2 million.

Per-company exclusion calculation

For each company, the exclusion is the greater of $10 million or 10x basis:

  • DataPath: $200,000 basis; 10x = $2 million. Greater is $10 million. Gain = $13.2M − $0.2M = $13.0M. Excluded: $10M. Taxable: $3.0M.
  • InferLab: $400,000 basis; 10x = $4 million. Greater is $10 million. Gain = $12.6M − $0.4M = $12.2M. Excluded: $10M. Taxable: $2.2M.
  • QueueShift: $1 million basis; 10x = $10 million. Greater is $10 million. Gain = $13.5M − $1.0M = $12.5M. Excluded: $10M. Taxable: $2.5M.
  • RegEdge: $1.5 million basis; 10x = $15 million. Greater is $15 million. Gain = $14.4M − $1.5M = $12.9M. Excluded: $12.9M (fully excluded under 10x rule). Taxable: $0.
  • Vectorline: $2 million basis; 10x = $20 million. Greater is $20 million. Gain = $13.2M − $2.0M = $11.2M. Excluded: $11.2M (fully excluded under 10x rule). Taxable: $0.

Combined federal tax outcome

  • Total proceeds (founder share, 5 exits): $66.9 million
  • Total gain: $61.8 million
  • Total excluded under section 1202: $54.1 million
  • Taxable gain: $7.7 million
  • Federal tax at 23.8% (20% LTCG + 3.8% NIIT): $1,832,600
  • Effective federal rate on $66.9M of proceeds: 2.7%

Without QSBS stacking — if all five companies had been divisions of a single C-corporation — the cumulative gain of $61.8 million would have been capped at $10 million of exclusion. Taxable gain: $51.8 million. Federal tax at 23.8%: $12,328,400. Stacking across five issuers saved the founder $10,495,800 in federal tax on the same operating outcome.

What kills a stacking strategy: the disqualification traps

Stacking is statutorily simple. The execution risks are the traps that disqualify one or more companies in the stack.

  • Starting as an LLC. If any company in the stack was originally formed as an LLC taxed as a partnership and later converted to a C-corp, the pre-conversion equity is not QSBS. Only stock issued after the C-corp election qualifies, and the 5-year holding period restarts at conversion. For stackers, the rule is: incorporate as a C-corp from day one.
  • Crossing the $50M gross-asset test. A successful late-stage fundraise can push gross assets above $50 million. Stock issued after the threshold is permanently non-QSBS — including additional founder grants, ISO/NSO exercises by employees, and any secondary issuances. The fix is to issue all intended founder stock before the financing that crosses the threshold, and to convert convertible instruments (SAFEs, notes) into QSBS-eligible stock at favorable pre-money valuations to stay under the ceiling longer.
  • Significant redemptions under section 1202(c)(3). If the corporation redeems stock from the taxpayer or related persons in significant amounts within specified periods (generally 2 years before and 2 years after the issuance), the stock can be disqualified. Founder buybacks and tender offers must be structured carefully, with attention to the de minimis thresholds.
  • Excluded business activity. If one of the five companies pivots into a section 1202(e)(3) excluded industry — for example, a SaaS company that acquires a consulting practice and reorganizes — the 80% active-business test can fail. The failure is for that company only; the other four are unaffected.
  • Failure to file 83(b) elections. For founder stock issued in connection with services (subject to vesting), failing to file an 83(b) election within 30 days means the stock is not "transferred" for tax purposes until vesting. The QSBS holding-period clock starts at vesting, not at grant. For a 4-year vesting schedule, this delays the 5-year mark by up to 4 years.

Where 10x basis dominates the $10M cap in stacked exits

For founders who invest significant capital — not just sweat equity — the 10x basis alternative under section 1202(b)(1)(B) can exceed $10 million per issuer. A founder who invests $2 million in cash into a C-corp at original issuance has $2 million of basis, generating a $20 million exclusion (10 × $2M). If the gain on that company exceeds $10 million but is less than $20 million, the 10x rule excludes more than the default $10 million cap.

In the worked example above, Companies 4 and 5 — where the founder invested $1.5M and $2M respectively — were fully excluded under the 10x rule because the founder's capital investment generated exclusion ceilings of $15M and $20M. This is how a founder with access to capital can shelter mid-eight-figure gains entirely. The lesson: in a stacking strategy, every dollar of basis creates $10 of exclusion capacity per issuer. Founders contemplating multiple exits should consider whether deploying personal capital into each company's capitalization yields meaningfully more exclusion than relying on the default $10M cap.

Concurrent vs sequential stacking

The worked example above mixed concurrent stacking (DataPath and InferLab overlapped) with sequential stacking (QueueShift, RegEdge, and Vectorline followed each prior exit). Both are statutorily permitted, but they raise different practical considerations.

Sequential stacking — found Company A, sell it, then found Company B — has the cleanest defensive posture. Each company has unambiguous operational independence. The risk of IRS attack on the basis that the companies are not separate trades or businesses (under section 269 or general step-transaction principles) is essentially zero.

Concurrent stacking — running multiple C-corps simultaneously — raises the question of whether the entities are genuinely separate. Defensible concurrent stacks have separate boards, separate cap tables, separate employees, separate customers, no significant intercompany contracts, and arms-length pricing on any shared services or licensing. Common-control between the entities is itself not disqualifying — section 1202 has no common-control aggregation rule — but operational separation must be real.

For a serial founder genuinely running multiple businesses in parallel, the stacking benefit is fully available. For a founder attempting to divide a single business into multiple legal entities purely to multiply QSBS exclusions, the IRS could attack the structure under economic-substance doctrines. The line is drawn at genuine business independence.

How state conformity intersects with stacking

Federal section 1202 stacking generates the $50 million exclusion in the worked example. State conformity determines whether that exclusion survives at the state level. State treatment falls into three categories:

  • Full conformity / no state income tax: Texas, Florida, Nevada, Washington, Wyoming, South Dakota, Tennessee, Alaska, New Hampshire (interest/dividend tax only). Federal QSBS exclusion preserved at zero state cost.
  • Federal conformity states with income tax: New York, Massachusetts, Illinois, and many others that adopt the Internal Revenue Code with limited modifications generally honor the federal section 1202 exclusion.
  • Non-conformity states: California taxes 100% of the federally excluded gain at the state level (top rate 13.3%); Pennsylvania (3.07%), New Jersey (10.75%), and a few others impose state tax on federally excluded QSBS gain regardless of holding period or qualification.

For the worked example, if the founder were a California resident at all five sale dates, the $54.1 million of federally excluded gain would be subject to California capital gains tax at up to 13.3% — adding roughly $7.2 million in state tax to a federally $1.8 million bill. Pre-sale residency planning is the largest controllable variable for west-coast founders attempting to stack.

Where the strategy is the wrong call

Stacking is not free. The administrative, legal, and accounting overhead of running five separate C-corporations — five tax returns, five sets of books, five cap tables, five sets of corporate formalities — costs real money. For a founder whose realistic exit value is $5 million per company, the absolute tax savings from stacking may not justify the structural complexity, especially when contrasted with a single company that captures the same enterprise value with one $10 million exclusion.

The strategy is most valuable when each company in the stack has plausible exit value approaching or exceeding the $10 million exclusion ceiling — that is, when each exit would generate $10 million+ of taxable gain absent the stacking. For founders building multiple companies with $25M+ exit potential each, the math is overwhelming. For founders running multiple small businesses with $3M exits, simpler structures often dominate.

Sequencing with section 1045 for compressed timelines

If a stacking founder needs to exit one company before its 5-year mark — common in M&A scenarios where the acquirer dictates timing — IRC section 1045 provides a bridge. The taxpayer sells the pre-5-year QSBS, reinvests the proceeds in replacement QSBS within 60 days, and the original holding period tacks onto the replacement stock. The 5-year clock continues across the rollover.

For a stack, this means a founder who exits Company A at year 3 can roll into Company B's stock and need only hold Company B for 2 additional years to claim the full section 1202 exclusion on the original gain. The replacement issuer's own $10 million cap remains available for any additional gain on Company B's subsequent sale. Section 1045 does not multiply exclusions — it preserves holding-period continuity across issuers — but for compressed stacks, it is the operational mechanism that makes the strategy work.

Key takeaways

  • IRC section 1202(b)(1) caps the QSBS exclusion at the greater of $10 million or 10x basis per issuer, not per taxpayer. There is no aggregate cap across companies. Five qualifying C-corps generate five independent exclusions for a combined $50 million ceiling.
  • Each company must independently satisfy all five section 1202 gates: domestic C-corp at original issuance, gross assets under $50 million at issuance, active qualified trade or business (80% test), original issuance to the taxpayer, and 5-year holding period from each company's stock-issuance date.
  • Failure in one company disqualifies that company's exclusion but does not affect the others. Stacking is robust to individual-company failure.
  • The 10x basis alternative can exceed the $10 million default for founders who invest significant capital. Every dollar of basis creates $10 of exclusion capacity per issuer — relevant when individual exits exceed $10 million in gain.
  • Concurrent stacking (multiple C-corps run simultaneously) is statutorily permitted but requires genuine operational independence to survive IRS scrutiny. Sequential stacking is the cleanest defensive posture.
  • State conformity is the largest residual variable. California taxes 100% of federally excluded QSBS gain at up to 13.3%; Texas, Florida, and other no-income-tax states preserve the federal exclusion at zero state cost.
  • Section 1045 rollover bridges exits across stacked issuers when the 5-year holding period on an outgoing company has not yet expired. It preserves holding-period continuity into replacement QSBS without consuming the replacement issuer's $10 million cap.

Join the 2026 tax newsletter

Decision checklists + key 2026 federal/state numbers. Free, one click.

Found this useful? Share it.
Share

Frequently asked

No. IRC section 1202(b)(1) defines the exclusion cap as the greater of $10 million or 10 times basis 'per issuer.' The statute does not impose any aggregate cap across issuers. A founder who holds qualified small business stock in five separate C-corporations, each independently meeting the section 1202 requirements, can exclude up to $10 million of gain from each issuer — a combined $50 million federal capital gains exclusion. The IRS has never published guidance suggesting an aggregate limitation, and the legislative history of section 1202 (originally enacted in 1993 and expanded by the Creating Small Business Jobs Act of 2010) supports the per-issuer reading. The practical limitation is that each company must independently qualify: domestic C-corporation status, gross assets under $50 million at issuance, active conduct of a qualified trade or business, and a 5-year holding period running separately from each company's stock-issuance date.

Yes, with one significant nuance. IRC section 1202 does not impose any industry-overlap restriction across separately incorporated issuers. A founder who runs five separate SaaS C-corporations — even five companies in the same vertical — gets five independent exclusions, provided each entity is a legitimate operating company with its own customers, contracts, employees, and revenue. The risk is the IRS arguing that the entities are not separate trades or businesses but rather artificial divisions of a single enterprise structured to multiply exclusions. The defenses are factual: separate boards, separate employees, separate customer bases, separate cap tables, no significant intercompany transactions, and arms-length pricing on any shared services. Section 269 (acquisitions made to evade tax) is a theoretical attack vector but rarely applied to operating businesses with genuine economic substance. The cleanest cases are sequential — found Company A, sell it, then found Company B — but concurrent stacking is also defensible when each entity has real operational independence.

Yes. The 5-year holding period under IRC section 1202(b)(2) runs independently from each company's stock-issuance date. Holding Company A for 7 years does not credit any holding-period time to Company B. If you incorporate Company A in 2020 and Company B in 2022, the 5-year clock on Company A expires in 2025 and on Company B in 2027 — you cannot sell Company B's stock before March 2027 and claim the 100% exclusion. The only exception is IRC section 1045 rollover: if you sell pre-5-year QSBS and reinvest the proceeds in replacement QSBS within 60 days, the holding period of the original stock tacks onto the replacement stock. This can compress the time between exits in a stacking strategy but does not allow simultaneous stacking before the cumulative 5-year threshold is reached on each separate issuer.

Stock issued by a corporation after the corporation's aggregate gross assets exceed $50 million is permanently disqualified from QSBS treatment under IRC section 1202(d)(1). The disqualification is issuance-date-specific — stock issued before the $50 million threshold was crossed remains qualified, and the founder can still claim the exclusion on that pre-threshold stock. But new stock issued after the company crosses $50 million (including additional founder grants, secondary issuances, or option exercises) does not qualify, regardless of how the proceeds are used. The failure in one company does not affect the QSBS status of stock in the founder's other companies — each is tested independently. The practical consequence: if Company B raises a Series C that pushes gross assets above $50 million, the founder's pre-Series-C stock is still QSBS, but no further QSBS can be issued by Company B. The other four companies in the stack continue unaffected, provided each remains under its own $50 million ceiling.

Section 1045 allows a taxpayer who sells QSBS held more than 6 months to defer the gain by purchasing replacement QSBS within 60 days. The replacement stock inherits the holding period of the sold stock — the 5-year clock continues rather than restarting. For stacking purposes, this is powerful: a founder who exits Company A at year 3 (before the 5-year mark) can roll the proceeds into Company B's stock and need only hold Company B for 2 additional years to reach the 5-year threshold and claim the section 1202 exclusion on the combined gain. The deferred gain reduces basis in the replacement stock, but the per-issuer $10 million cap on Company B remains available. Section 1045 does not multiply exclusions — it defers gain into replacement QSBS that will eventually use the replacement issuer's $10 million cap. For pure stacking (multiple sales across multiple issuers, each held the full 5 years), section 1045 is not needed; for compressed exit timelines, it is the bridge between issuers.

Related guides

QSBS Stacking: Multiple Companies, Multiple Exclusions

The foundational guide to per-issuer mechanics of the section 1202 exclusion. For founders evaluating a 5-company stacking strategy, this post explains the statutory basis for per-issuer treatment and the disqualification traps that apply across all stacked companies.

Section 1045 Rollover: Preserving QSBS Holding Period

When a serial founder exits one company before the 5-year mark, section 1045 lets the gain roll into replacement QSBS in the next company while preserving the original holding period. Essential for stacking on compressed timelines.

QSBS Exemption Stacking via Spouse Plus Non-Grantor Trust

Per-issuer stacking is one axis of QSBS multiplication. Per-taxpayer stacking — spreading QSBS across spouses and non-grantor trusts — is the other. Combined, the two strategies can generate $30 million+ of exclusion on a single company.

QSBS State Conformity Matrix: California Disqualifies, Texas and Florida Conform

Federal stacking generates the $50 million exclusion. State conformity determines whether that exclusion survives at the state level. California's nonconformity can claw back 13.3% of every dollar federally excluded — the highest-stakes variable for west-coast founders.

Asset Sale vs Stock Sale: Founder vs Buyer Negotiation

The section 1202 exclusion applies only to stock sales — asset sales of a C-corporation forfeit QSBS treatment entirely. For founders stacking exclusions across 5 companies, preserving stock-sale structure in each exit is the threshold question.

Free newsletter

Join the Life Money USA newsletter

Decision checklists, 2026 federal + state numbers, and our glossary. One click, free.

Join the newsletter